Sunshine Biopharma Inc.
13F holders, Q1 2025 (March 31)11holders −1
1new positions
2sold out
$1.91avg. 13F price*
At the end of Q1 2025, 11 institutions reported holding Sunshine Biopharma Inc. in their 13F filings, down 1 from Q4 2024. 1 opened new positions and 2 sold out. The largest holders were Altium Capital Management LLC ($96K), UBS Group AG ($38K) and SBI Securities Co., Ltd. ($10K).
- Company
- Sunshine Biopharma Inc.
- CUSIP
- 867781700
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $96K |
| Exits | 2 | $34K |
All 13F filers, Q4 2024 → Q1 2025: 74,000 shares bought and 15,155 shares sold, net +58,845 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 11 holders
| Altium Capital Management LLC | 0.28% | New | 50,466 | $96K |
| UBS Group AG | 0.00% | Add +2190.9% | 19,885 | $38K |
| SBI Securities Co., Ltd. | 0.00% | Add +636.7% | 5,223 | $10K |
| Morgan Stanley | 0.00% | Reduce -49.8% | 3,834 | $7K |
| National Bank of Canada | 0.00% | Add +42.9% | 10 | $19 |
| Bank of America Corp. | 0.00% | No change | 5 | $10 |
| Osaic Holdings, Inc. | 0.00% | No change | 2 | $2 |
| Rise Advisors, LLC | 0.00% | No change | 1 | $2 |
| Farther Finance Advisors, LLC | 0.00% | No change | 1 | $2 |
| TD Waterhouse Canada Inc. | 0.00% | No change | 1 | $2 |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 1 | $2 |
"% of holder's portfolio" is SUNSHINE BIOPHARMA INC's weight in each manager's 13F, not the share of Sunshine Biopharma Inc. the manager owns.